Interní Med. 2004; 6(6): 309-311

Léčba akutních koronárních syndromů bez ST elevací v reálné praxi

MUDr. Marian Bystroň
Kardiologické oddělení, Masarykova nemocnice v Ústí nad Labem

Keywords: acute coronary syndrom, risk stratification, therapy, therapy management.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň M. Léčba akutních koronárních syndromů bez ST elevací v reálné praxi. Interní Med. 2004;6(6):309-311.

Přehledný článek shrnuje současnou léčbu akutních koronární syndromů bez elevací ST-segmentu v běžné praxi. Důraz je kladen na hodnocení rizika pacientů a význam spolupráce regionálních nemocnic a kardiocenter.

Treatement of acute coronary syndromes without ST-segment elevation in real practice

The review article summarize recent treatement of acute coronary syndromes without ST-segment elevation in real practice. The risk stratification and necessity of cooperation among local hospitals and cardiocenters are stressed.

Download citation

References

  1. Bertrand ME, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2002; 23: 1809-1840. Go to original source... Go to PubMed...
  2. Braunwald E, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. ACC/AHA practice guidelines 2002.
  3. Karmazín V. Novinky v diagnostice a léčbě akutních koronárních syndromů. Interní medicína pro praxi 2004; 1: 6-8.
  4. Widimský P. Akutní koronární syndromy. Kardiofórum 2003; 2: 7.
  5. RISC Group. Risk of myocardial infarction and death during treatmen with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-830. Go to original source...
  6. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin and risk factor modification. JAMA 1988; 260: 2259-2263. Go to original source... Go to PubMed...
  7. Elliot A, et al. Thrombolysis in myocardial infarction 11B. Eur Heart J 1999; 20: 7-10.
  8. Randomized placebo-controlled trial of abciximab before a and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997; 349: 1429-1435.
  9. Cannon CP, at al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban. JAMA 2001; 286: 2405-2412. Go to PubMed...
  10. Špaček R, et al. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction. An open multicenter randomized trial: the VINO study. Eur Heart J 2002; 23: 230-238. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.